Norman Broadbent PLC
14 August 2026
Norman Broadbent plc
("Norman Broadbent" or the "Company")
Grant of new options
Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, with an ambitious growth plan to scale the business through disciplined investment in fee-earning capacity, announces that , on 14 August 2026, (the "Date of Grant"), it granted options over, in aggregate, 345,000 ordinary shares of £0.05 each ("Ordinary Shares") in the Company ("Options") to both Executive Directors and certain employees (the "Grant") under its Enterprise Management Incentive Share Option Scheme (the "Scheme"). The Options are exercisable at nominal value of five pence per Ordinary Share.
The Options will vest over a three-year period from date of grant and are subject to the achievement of three performance conditions. Up to 50% of the Options will vest based on cumulative Net Fee Income performance, up to 30% based on the Company's share price performance, and the remaining 20% based on cumulative underlying EBITDA[1] performance.
For the Net Fee Income target, vesting begins at £40.6m and reaches full vesting at £49.6m or above. For the share price target, vesting begins at an average share price of £2.50 and reaches full vesting at £4.50 or above. For the EBITDA target, vesting begins at £2.8m and reaches full vesting at £3.4m or above.
The following table sets out details of the Options that have been granted to the Executive Directors and one person discharging managerial responsibilities ("PDMR"):
|
Name of Individual |
Director/PDMR |
Total Number of Options granted |
Percentage of the Company's Existing Issued Share Capital |
Percentage of the Company's Fully Diluted Share Capital held[2] |
|
Kevin Davidson |
CEO |
85,750 |
4.3% |
3.4% |
|
Mehr Malik |
CFO |
56,750 |
2.8% |
2.3% |
|
Sean Bergin |
COO and PDMR |
56,750 |
2.8% |
2.3% |
|
Total |
199,250 |
[1] excludes share-based payment charges and restructuring costs.
[2] assuming that no further Ordinary Shares are issued between the date of this announcement and exercise of the Options.
Following the grant of the Options, there are 345,000 options over Ordinary Shares outstanding representing 17.2 per cent. of the Company's issued share capital. At the date of this announcement, the Company has 2,008,893 Ordinary Shares in issue.
The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation is appended further below.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||
|
a) |
Name |
|
||||||||||||
|
2 |
Reason for the notification |
|||||||||||||
|
a) |
Position/status |
See 1a) above |
||||||||||||
|
b)
|
Initial notification /Amendment |
Initial notification |
||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||
|
a) |
Name |
Norman Broadbent Plc |
||||||||||||
|
b) |
LEI |
213800E5YN5TA934XA23 |
||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Options over ordinary shares of £0.05 each in Norman Broadbent Plc Identification code (ISIN) for Norman Broadbent Plc ordinary shares: GB00B3VF4Y66 |
||||||||||||
|
b) |
Nature of the transaction |
Grant of options |
||||||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||||||
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||||||||||
|
e) |
Date of the transactions |
Options put in place as of 14 August 2026 |
||||||||||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||||||||||
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Contacts:
|
Norman Broadbent plc |
Via Gracechurch Group |
|
Kevin Davidson, CEO |
|
|
Mehr Malik, CFO |
|
|
Cavendish Capital Markets Limited (Nominated Adviser and Broker) |
+44 (0)20 7220 0500 |
|
Julian Blunt, Seamus Fricker, Andrea Callaghan - Corporate Finance |
|
|
Jasper Berry, Matt Lewis - Sales / Corporate Broking |
|
|
|
|
|
Gracechurch Group (Financial Media & Investor Relations ) |
+44 (0)20 4582 3500 |
|
Murdo Montgomery |
|
|
Tommy Bryson |
|
|
Anysia Virdi |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.